These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 18925434

  • 1. Comparing patients' and clinicians' assessment of outcomes in a randomised trial of sentinel node biopsy for breast cancer (the RACS SNAC trial).
    Smith MJ, Gill PG, Wetzig N, Sourjina T, Gebski V, Ung O, Campbell I, Kollias J, Coskinas X, Macphee A, Young L, Simes RJ, Stockler MR, Royal Australasian College of Surgeons SNAC Trial Group.
    Breast Cancer Res Treat; 2009 Sep; 117(1):99-109. PubMed ID: 18925434
    [Abstract] [Full Text] [Related]

  • 2. Lymphedema following breast cancer treatment, including sentinel lymph node biopsy.
    Armer J, Fu MR, Wainstock JM, Zagar E, Jacobs LK.
    Lymphology; 2004 Jun; 37(2):73-91. PubMed ID: 15328760
    [Abstract] [Full Text] [Related]

  • 3. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
    Husted Madsen A, Haugaard K, Soerensen J, Bokmand S, Friis E, Holtveg H, Peter Garne J, Horby J, Christiansen P.
    Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
    [Abstract] [Full Text] [Related]

  • 4. Comparison of volume displacement versus circumferential arm measurements for lymphoedema: implications for the SNAC trial.
    Tewari N, Gill PG, Bochner MA, Kollias J.
    ANZ J Surg; 2008 Oct; 78(10):889-93. PubMed ID: 18959643
    [Abstract] [Full Text] [Related]

  • 5. Shoulder-arm morbidity in patients with sentinel node biopsy and complete axillary dissection--data from a prospective randomised trial.
    Helms G, Kühn T, Moser L, Remmel E, Kreienberg R.
    Eur J Surg Oncol; 2009 Jul; 35(7):696-701. PubMed ID: 18838245
    [Abstract] [Full Text] [Related]

  • 6. Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer.
    Rietman JS, Dijkstra PU, Geertzen JH, Baas P, de Vries J, Dolsma WV, Groothoff JW, Eisma WH, Hoekstra HJ.
    Ann Surg Oncol; 2004 Nov; 11(11):1018-24. PubMed ID: 15525832
    [Abstract] [Full Text] [Related]

  • 7. Sentinel node biopsy and quality of life measures in a Chinese population.
    Chen JJ, Huang XY, Liu ZB, Chen TW, Cheng JY, Yang WT, Xu WP, Shao ZM, Shen ZZ, Wu J.
    Eur J Surg Oncol; 2009 Sep; 35(9):921-7. PubMed ID: 19233602
    [Abstract] [Full Text] [Related]

  • 8. Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial.
    Purushotham AD, Upponi S, Klevesath MB, Bobrow L, Millar K, Myles JP, Duffy SW.
    J Clin Oncol; 2005 Jul 01; 23(19):4312-21. PubMed ID: 15994144
    [Abstract] [Full Text] [Related]

  • 9. Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer.
    Fleissig A, Fallowfield LJ, Langridge CI, Johnson L, Newcombe RG, Dixon JM, Kissin M, Mansel RE.
    Breast Cancer Res Treat; 2006 Feb 01; 95(3):279-93. PubMed ID: 16163445
    [Abstract] [Full Text] [Related]

  • 10. Long-term morbidity of sentinel node biopsy versus complete axillary dissection for unilateral breast cancer.
    Crane-Okada R, Wascher RA, Elashoff D, Giuliano AE.
    Ann Surg Oncol; 2008 Jul 01; 15(7):1996-2005. PubMed ID: 18415650
    [Abstract] [Full Text] [Related]

  • 11. Early self-reported impairments in arm functioning of primary breast cancer patients predict late side effects of axillary lymph node dissection: results from a population-based cohort study.
    Albert US, Koller M, Kopp I, Lorenz W, Schulz KD, Wagner U.
    Breast Cancer Res Treat; 2006 Dec 01; 100(3):285-92. PubMed ID: 16710790
    [Abstract] [Full Text] [Related]

  • 12. Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial.
    Del Bianco P, Zavagno G, Burelli P, Scalco G, Barutta L, Carraro P, Pietrarota P, Meneghini G, Morbin T, Tacchetti G, Pecoraro P, Belardinelli V, De Salvo GL, GIVOM.
    Eur J Surg Oncol; 2008 May 01; 34(5):508-13. PubMed ID: 17614245
    [Abstract] [Full Text] [Related]

  • 13. Lymphoedema and reduced shoulder function as indicators of quality of life after axillary lymph node dissection for invasive breast cancer.
    Voogd AC, Ververs JM, Vingerhoets AJ, Roumen RM, Coebergh JW, Crommelin MA.
    Br J Surg; 2003 Jan 01; 90(1):76-81. PubMed ID: 12520579
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer.
    Rietman JS, Geertzen JH, Hoekstra HJ, Baas P, Dolsma WV, de Vries J, Groothoff JW, Eisma WH, Dijkstra PU.
    Eur J Surg Oncol; 2006 Mar 01; 32(2):148-52. PubMed ID: 16387467
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Sentinel-Lymph-Node-Based Management or Routine Axillary Clearance? Five-Year Outcomes of the RACS Sentinel Node Biopsy Versus Axillary Clearance (SNAC) 1 Trial: Assessment and Incidence of True Lymphedema.
    Wetzig N, Gill PG, Espinoza D, Mister R, Stockler MR, Gebski VJ, Ung OA, Campbell I, Simes J.
    Ann Surg Oncol; 2017 Apr 01; 24(4):1064-1070. PubMed ID: 27848050
    [Abstract] [Full Text] [Related]

  • 19. The consequences of long-time arm morbidity in node-negative breast cancer patients with sentinel node biopsy or axillary clearance.
    Leidenius M, Leivonen M, Vironen J, von Smitten K.
    J Surg Oncol; 2005 Oct 01; 92(1):23-31. PubMed ID: 16180231
    [Abstract] [Full Text] [Related]

  • 20. Short-term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for Stage I or II breast carcinoma.
    Rietman JS, Dijkstra PU, Geertzen JH, Baas P, De Vries J, Dolsma W, Groothoff JW, Eisma WH, Hoekstra HJ.
    Cancer; 2003 Aug 15; 98(4):690-6. PubMed ID: 12910511
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.